surmount-1 tirzepatide weight loss results Before and after results: what real transformations look like and what determines success SURMOUNT-1: Tirzepatide Drastically Reduces Weight

Zepbound (tirzepatide) is a once-weekly subcutaneous GLP-1 receptor agonist and GIP receptor agonist indicated for chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity such as hypertension, type 2 diabetes, or dyslipidemia

Stay hydrated and active to support digestion, energy, and long-term weight maintenance while on tirzepatide

Handling Missed Doses and Schedule Changes Life is unpredictable, and there may be times when you forget your injection or cannot take it on your usual day

Eligibility for Prescription Weight Loss Treatment Weight loss medications approved by the FDA can typically be prescribed for individuals with a BMI of 30 or above, or a BMI of 27 with accompanying health issues like type 2 diabetes, elevated blood pressure, or high cholesterol